More than 170 representatives from academia, the Ontario and Québec governments, multi-national pharmaceutical companies, biotech companies, and contract research organizations attended the session, titled “Rare Disease and Genomics in 3D: From Diagnostics to Data to Drug Discovery and Development.”
This year’s Clinical Trials Ontario (CTO) conference welcomed a select group of Ontario-based health care start-ups to exhibit at its first-ever Innovation Showcase.
New technologies such as artificial intelligence and digital health applications, and how they impact research, were key topics at this year’s Clinical Trials Ontario (CTO) conference.
The need for patient engagement in all aspects of clinical trials was an important theme of this year’s Clinical Trials Ontario (CTO) annual conference in Toronto.
Clinical Trials Ontario is a collaborator in an international group working on ways to enhance meaningful patient engagement in developing new medicines. The Patient-Focused Medicines Development initiative, which includes CTO, recently published a paper in the journal BMJ Innovations. The paper provides guidance and core principles which can be applied and adapted across the medicines’ development lifecycle, at the start, during, or even at the evaluation stage of a project.
Clinical Trials Ontario in partnership with Women’s College Hospital Institute for Health System Solutions and Virtual Care (WIHV), St. Michael’s Applied Health Research Centre (AHRC), TOHealth!, and University of Toronto’s H2i is hosting a lunch educational event discussing clinical trials. What is a clinical trial? Do you need one? What resources exist to help you run one? These are all questions we will answer with presentations and a panel of local experts who represent the organizations who are here to help.